Pharmaceutical companies Teva and Cephalon must pay 60.5 million euros in fines ($72 million) after the European Commission concluded the companies agreed to delay the market entry of a cheaper drug to treat sleep disorders. The probe focused on modafinil and sees the EU regulator again sanction conduct where pharmaceutical companies exchange